Although our immunoassay portfolio includes >1,000 biomarkers in over 200 kits for the Single Molecule Counting (SMC®) and Luminex® platforms, we may not always have the assay you need to detect your biomarker or biomarkers of interest. When you don’t have the time or resources to develop your own assay, our Custom Assay Development & Innovation CADI team is here to help.
Whether you need to develop new biomarker assays, combine existing analytes into new multiplex panels, adapt your assay to a new platform for higher sensitivity, or manufacture an immunoassay kit for novel targets of interest, CADI provides innovative, best-in-class solutions to meet your specific immunoassay requirements and accelerate your research.
For more information about CADI and our custom assay services, visit us at SigmaAldrich.com/customassay or contact your local Field Application Scientist or Immunoassay Platforms Solutions Specialist.
For Research Use Only. Not For Use In Diagnostic Procedures.
MilliporeSigma is the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany.
More Info